Novo Nordisk A/S (NVO) scores 56 out of 100 on boothcheck's 11-model valuation framework. Verdict: Hold The estimated fair value is $302.94, representing a 87% margin of safety.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.